FDA IDE pathway
Navigate investigational device exemption requirements with confidence and precision
Pathway
Understanding the Investigational Device Exemption
The IDE is your legal authorization to conduct clinical investigations with an unapproved medical device. It bridges the gap between laboratory development and market-ready products by allowing real-world testing under FDA oversight.
Requirements
Three essential steps for IDE approval
The FDA requires comprehensive documentation before granting IDE status. Your submission must demonstrate that your device can be safely tested in human subjects.
Study protocol submission
Submit detailed clinical protocols outlining your investigation design and methodology.
IRB approval
Obtain institutional review board approval before beginning any human subject testing.
Safety and effectiveness data
Provide nonclinical and previous human experience data supporting device safety.
Process
How to navigate the IDE approval pathway
The IDE approval process moves quickly when your application is complete and well-organized. The FDA typically responds within thirty days, though complex neurological devices may require additional review time.
Prepare comprehensive device documentation
Gather manufacturing specs and safety protocols
Submit application and await FDA determination
Questions
Find answers to common questions about FDA IDE requirements and regulatory pathways
An Investigational Device Exemption allows manufacturers to conduct clinical studies with devices not yet approved by the FDA. It provides the regulatory pathway to gather safety and effectiveness data necessary for market approval. The IDE process is essential for bringing new neurological devices to clinical practice.
Sponsors planning a clinical investigation of an unapproved medical device may need an IDE, particularly when the study presents significant risk to participants.
The FDA typically responds within thirty days when an application is complete, although complex neurological devices can require additional review time.
An IDE submission should include the study protocol, risk analysis, investigator qualifications, informed-consent materials, device details, and the available safety and effectiveness evidence.
A study can be expanded when the sponsor submits the required IDE supplement or amendment and obtains the applicable FDA and institutional review board approvals.
